SLC38A2 Provides Proline to Fulfill Unique Synthetic Demands Arising During Osteoblast Differentiation and Bone Formation

Overview

Journal Elife

Specialty Biology

Date 2022 Mar 9

PMID 35261338

Authors

Leyao Shen

Yilin Yu

Yunji Zhou

Shondra M Pruett-Miller

Guo-Fang Zhang

Courtney M Karner

Affiliations

Soon will be listed here.

Abstract

Cellular differentiation is associated with the acquisition of a unique protein signature that is essential to attain the ultimate cellular function and activity of the differentiated cell. This is predicted to result in unique biosynthetic demands that arise during differentiation. Using a bioinformatic approach, we discovered that osteoblast differentiation is associated with increased demand for the amino acid proline. When compared to other differentiated cells, osteoblast-associated proteins, including RUNX2, OSX, OCN, and COL1A1, are significantly enriched in proline. Using a genetic and metabolomic approach, we demonstrate that the neutral amino acid transporter SLC38A2 acts cell-autonomously to provide proline to facilitate the efficient synthesis of proline-rich osteoblast proteins. Genetic ablation of SLC38A2 in osteoblasts limits both osteoblast differentiation and bone formation in mice. Mechanistically, proline is primarily incorporated into nascent protein with little metabolism observed. Collectively, these data highlight a requirement for proline in fulfilling the unique biosynthetic requirements that arise during osteoblast differentiation and bone formation.

Citing Articles

Integrating 16S rRNA Gene Sequencing and Metabolomics Analysis to Reveal the Mechanism of L-Proline in Preventing Autism-like Behavior in Mice.

Fang J, Kang S, Huang K, Tong T Nutrients. 2025; 17(2).

PMID: 39861379 PMC: 11767903. DOI: 10.3390/nu17020247.

Energy metabolism in osteoprogenitors and osteoblasts: Role of the pentose phosphate pathway.

Catheline S, Smith C, McArthur M, Yu C, Brookes P, Eliseev R J Biol Chem. 2024; 301(1):108016.

PMID: 39608710 PMC: 11721538. DOI: 10.1016/j.jbc.2024.108016.

The facilitated osteogenic differentiation by extracellular proline treatment in in vitro cell cultivation using MC3T3E1 and hPDLF.

Son S, Kim A, Jang J, Pokharel E, Rana B, Kim T Genes Genomics. 2024; 47(2):157-169.

PMID: 39567419 DOI: 10.1007/s13258-024-01588-6.

Mechanisms of assembly and remodelling of the extracellular matrix.

Naba A Nat Rev Mol Cell Biol. 2024; 25(11):865-885.

PMID: 39223427 DOI: 10.1038/s41580-024-00767-3.

Metabolic control of collagen synthesis.

Guillard J, Schworer S Matrix Biol. 2024; 133:43-56.

PMID: 39084474 PMC: 11402592. DOI: 10.1016/j.matbio.2024.07.003.

References

Otto F, Thornell A, Crompton T, Denzel A, Gilmour K, Rosewell I . Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997; 89(5):765-71. DOI: 10.1016/s0092-8674(00)80259-7. View

Elia I, Broekaert D, Christen S, Boon R, Radaelli E, Orth M . Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells. Nat Commun. 2017; 8:15267. PMC: 5437289. DOI: 10.1038/ncomms15267. View

Meyer M, Benkusky N, Lee C, Pike J . Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation. J Biol Chem. 2014; 289(28):19539-54. PMC: 4094065. DOI: 10.1074/jbc.M114.578104. View

Zhang A, Yu W, Ma B, Yu X, Mao F, Liu W . Proteomic identification of differently expressed proteins responsible for osteoblast differentiation from human mesenchymal stem cells. Mol Cell Biochem. 2007; 304(1-2):167-79. DOI: 10.1007/s11010-007-9497-3. View

Phang J, Liu W, Hancock C, Christian K . The proline regulatory axis and cancer. Front Oncol. 2012; 2:60. PMC: 3380417. DOI: 10.3389/fonc.2012.00060. View

Jagannathan-Bogdan M, Zon L . Hematopoiesis. Development. 2013; 140(12):2463-7. PMC: 3666375. DOI: 10.1242/dev.083147. View

Takarada T, Nakazato R, Tsuchikane A, Fujikawa K, Iezaki T, Yoneda Y . Genetic analysis of Runx2 function during intramembranous ossification. Development. 2015; 143(2):211-8. DOI: 10.1242/dev.128793. View

Olivares O, Mayers J, Gouirand V, Torrence M, Gicquel T, Borge L . Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions. Nat Commun. 2017; 8:16031. PMC: 5504351. DOI: 10.1038/ncomms16031. View

Hahn T, DOWNING S, Phang J . Insulin effect on amino acid transport in bone: dependence on protein synthesis and Na+. Am J Physiol. 1971; 220(6):1717-23. DOI: 10.1152/ajplegacy.1971.220.6.1717. View

10.

Liu W, Phang J . Proline dehydrogenase (oxidase), a mitochondrial tumor suppressor, and autophagy under the hypoxia microenvironment. Autophagy. 2012; 8(9):1407-9. PMC: 3442893. DOI: 10.4161/auto.21152. View

11.

Ducy P, Zhang R, Geoffroy V, Ridall A, Karsenty G . Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997; 89(5):747-54. DOI: 10.1016/s0092-8674(00)80257-3. View

12.

Buttgereit F, Brand M . A hierarchy of ATP-consuming processes in mammalian cells. Biochem J. 1995; 312 ( Pt 1):163-7. PMC: 1136240. DOI: 10.1042/bj3120163. View

13.

Grewal S, Defamie N, Zhang X, De Gois S, Shawki A, Mackenzie B . SNAT2 amino acid transporter is regulated by amino acids of the SLC6 gamma-aminobutyric acid transporter subfamily in neocortical neurons and may play no role in delivering glutamine for glutamatergic transmission. J Biol Chem. 2009; 284(17):11224-36. PMC: 2670127. DOI: 10.1074/jbc.M806470200. View

14.

Bianco P, Fisher L, Young M, Termine J, Robey P . Expression of bone sialoprotein (BSP) in developing human tissues. Calcif Tissue Int. 1991; 49(6):421-6. DOI: 10.1007/BF02555854. View

15.

Baum B, Shteyer A . Characteristics of a neutral amino acid transport system (system A) in osteoblastic rat osteosarcoma cells. Exp Cell Res. 1987; 169(2):453-7. DOI: 10.1016/0014-4827(87)90205-9. View

16.

Liu W, Glunde K, Bhujwalla Z, Raman V, Sharma A, Phang J . Proline oxidase promotes tumor cell survival in hypoxic tumor microenvironments. Cancer Res. 2012; 72(14):3677-86. PMC: 3399032. DOI: 10.1158/0008-5472.CAN-12-0080. View

17.

Loayza-Puch F, Rooijers K, Buil L, Zijlstra J, Oude Vrielink J, Lopes R . Tumour-specific proline vulnerability uncovered by differential ribosome codon reading. Nature. 2016; 530(7591):490-4. DOI: 10.1038/nature16982. View

18.

Hollinshead K, Munford H, Eales K, Bardella C, Li C, Escribano-Gonzalez C . Oncogenic IDH1 Mutations Promote Enhanced Proline Synthesis through PYCR1 to Support the Maintenance of Mitochondrial Redox Homeostasis. Cell Rep. 2018; 22(12):3107-3114. PMC: 5883319. DOI: 10.1016/j.celrep.2018.02.084. View

19.

Yang X, Matsuda K, Bialek P, Jacquot S, Masuoka H, Schinke T . ATF4 is a substrate of RSK2 and an essential regulator of osteoblast biology; implication for Coffin-Lowry Syndrome. Cell. 2004; 117(3):387-98. DOI: 10.1016/s0092-8674(04)00344-7. View

20.

Rodda S, McMahon A . Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors. Development. 2006; 133(16):3231-44. DOI: 10.1242/dev.02480. View